| Mr James William Johnson, MS CCCA | |
|
2385 E Prater Way Suite 205, Advance Audiology, Sparks, NV 89434-7688 | |
| (775) 358-4007 | |
| (775) 358-4405 |
| Full Name | Mr James William Johnson |
|---|---|
| Gender | Male |
| Speciality | Audiologist |
| Location | 2385 E Prater Way Suite 205, Sparks, Nevada |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194982504 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 00686394 (Nevada) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr James William Johnson, MS CCCA 2385 E Prater Way, Advance Audiology, Sparks, NV 89434-7688 Ph: (775) 358-4007 | Mr James William Johnson, MS CCCA 2385 E Prater Way Suite 205, Advance Audiology, Sparks, NV 89434-7688 Ph: (775) 358-4007 |
News Archive
"Much of the $19 billion in foreign aid that the United States has pumped into Afghanistan in the past decade may be fueling development on the ground in the short term, but is unlikely to produce change that will last once U.S. troops depart, according to a new congressional report," the Christian Science Monitor reports.
The discovery provides insight into a protein, renin, that is important in blood pressure regulation, and reveals the cause of one type of inherited kidney disease occurring in adults and children, said co-investigator Anthony Bleyer, M.D., professor of internal medicine-nephrology at the School of Medicine.
Heralded a miracle by many infertile couples, in vitro fertilization (IVF) can pack a painful financial punch for those without insurance coverage for the treatment. This prohibitive cost leads many would-be parents who pursue in vitro fertilization to transfer multiple embryos at once to increase their chances of getting a baby - and reduce the need to pay for subsequent attempts.
Intra-Cellular Therapies, Inc. ("ITI") and Takeda Pharmaceutical Company Limited, today announced that they have entered into an exclusive collaboration to develop and commercialize selective phosphodiesterase type 1 (PDE1) inhibitors, discovered by ITI, for the treatment of cognitive impairment associated with schizophrenia. This agreement is targeted worldwide, but ITI has retained the option to co-promote with Takeda in the United States.
Now that President Barack Obama has signed America's new health care legislation into law, what will the future look like for Americans, both in using health care services and paying for them - especially as the population ages.
› Verified 2 days ago
Advanced Pediatric Therapies, Llc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1625 E Prater Way Ste 107, Sparks, NV 89434 Phone: 775-825-4744 Fax: 775-351-1644 |